2nd International Conference on Chemo and Bioinformatics ICCBIKG 2023 (682-685)
АУТОР(И) / AUTHOR(S): Žiko Milanović, Marko Antonijević, Dušica Simijonović, Jelena Đorović Jovanović, Marijana Stanojević Pirković
Е-АДРЕСА / E-MAIL: ziko.milanovic@uni.kg.ac.rs
DOI: 10.46793/ICCBI23.682M
САЖЕТАК / ABSTRACT:
Nasopharyngeal cancer (NPC) is a type of cancer that originates in the nasopharynx, which is the upper part of the throat behind the nasal cavity. Like other cancers, the growth and progression of nasopharyngeal cancer are influenced by various proteins involved in cell signaling, growth regulation, and tumor development such as Epidermal Growth Factor Receptor (EGFR), Vascular Endothelial Growth Factor (VEGF), Fibroblast growth factor receptor (FGFR) and Cyclin D1 (CD1). Megaphone ((1′R,5′R,7R,8S)-7-Hydroxy-3,4,5,5′-methoxy-5′,6′-dihydro-2′H-8,1′-neolign-8′-en-2′-one, MG) is the main component of the alcohol extract of the ground root of Aniba megaphylla, which in vitro inhibits the growth of cells derived from human nasopharyngeal carcinoma. Due to the lack of literature data, the main goal of this study was to examine the first step of the mechanisms of anti-carcinogenic activity by examining the inhibitory potential of MG against the above-mentioned cancer cell growth factor receptors.
КЉУЧНЕ РЕЧИ / KEYWORDS:
Megaphone, Nasopharyngeal cancer, EGFR, VGFR, FGFR
ЛИТЕРАТУРА / REFERENCES:
- C.Y.Mimi, J.M.Yuan., Epidemiology of nasopharyngeal carcinoma. In Seminars in cancer biology, Academic Press, 12 (2002) 421-429.
- D.A.Whiting., Lignans, neolignans, and related compounds. Natural Product Reports, 7 (1990) 349-364.
- J. Stamos, M.X. Sliwkowski, C. Eigenbrot., Structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitor. Journal of biological chemistry, 277 (2002) 46265-46272.
- M. McTigue, B.W.Murray, J.H. Chen, Y.L.Deng, J.Solowiej, R.S. Kania., Molecular conformations, interactions, and properties associated with drug efficiency and clinical performance among VEGFR TK inhibitors. Proceedings of the National Academy of Sciences, 109 (2012) 18281-18289.
- J.A.Tucker, T.Klein, J. Breed, A.L. Breeze, R. Overman, C. Phillips, R.A.Norman. Structural insights into FGFR kinase isoform selectivity: diverse binding modes of AZD4547 and ponatinib in complex with FGFR1 and FGFR4. Structure, 22 (2014) 1764-1774.
- P.J.Day, A. Cleasby, I.J. Tickle, M. O’Reilly, J.E.Coyle, F.P.Holding, H. Jhoti., Crystal structure of human CDK4 in complex with a D-type cyclin. Proceedings of the National Academy of Sciences, 106 (2009) 4166-4170.